1. Home
  2. XOMA vs FOF Comparison

XOMA vs FOF Comparison

Compare XOMA & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • FOF
  • Stock Information
  • Founded
  • XOMA 1981
  • FOF 2006
  • Country
  • XOMA United States
  • FOF United States
  • Employees
  • XOMA N/A
  • FOF N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • FOF Investment Managers
  • Sector
  • XOMA Health Care
  • FOF Finance
  • Exchange
  • XOMA Nasdaq
  • FOF Nasdaq
  • Market Cap
  • XOMA 319.3M
  • FOF 342.8M
  • IPO Year
  • XOMA N/A
  • FOF N/A
  • Fundamental
  • Price
  • XOMA $24.26
  • FOF $12.61
  • Analyst Decision
  • XOMA Strong Buy
  • FOF
  • Analyst Count
  • XOMA 2
  • FOF 0
  • Target Price
  • XOMA $72.00
  • FOF N/A
  • AVG Volume (30 Days)
  • XOMA 56.4K
  • FOF 58.7K
  • Earning Date
  • XOMA 03-07-2025
  • FOF 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • FOF 9.07%
  • EPS Growth
  • XOMA N/A
  • FOF N/A
  • EPS
  • XOMA N/A
  • FOF N/A
  • Revenue
  • XOMA $21,606,000.00
  • FOF N/A
  • Revenue This Year
  • XOMA $511.37
  • FOF N/A
  • Revenue Next Year
  • XOMA $26.92
  • FOF N/A
  • P/E Ratio
  • XOMA N/A
  • FOF N/A
  • Revenue Growth
  • XOMA 389.82
  • FOF N/A
  • 52 Week Low
  • XOMA $21.27
  • FOF $9.59
  • 52 Week High
  • XOMA $35.00
  • FOF $11.75
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 40.11
  • FOF 48.54
  • Support Level
  • XOMA $24.01
  • FOF $12.48
  • Resistance Level
  • XOMA $27.43
  • FOF $12.70
  • Average True Range (ATR)
  • XOMA 1.06
  • FOF 0.14
  • MACD
  • XOMA -0.14
  • FOF 0.01
  • Stochastic Oscillator
  • XOMA 22.51
  • FOF 65.12

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

Share on Social Networks: